Furthermore, FXR not only serves as a master regulator of BA homeostasis but also is closely associated with the development of cholestasis in clinical settings, underscoring its significance as a key therapeutic target for cholestatic liver diseases.45 Here, NR1H4 is linked to Cholestatic liver disease.